Clinical Trial Update: Evaluating the SUBLOCADE Treatment Exit Strategy

View source ↗

Summary

This clinical trial update discusses the exit strategy for SUBLOCADE in treating Opioid Use Disorder. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Status: COMPLETED